Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23099)

Formulation Name
Capmatinib eq 150mg base tablet
Company
Novartis Pharm
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Capmatinib DMYCXKL Non-small-cell lung cancer 2C25.Y Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Cellulose microcrystalline E00698 Not Available Adsorbent; Suspending agent; Diluent
Crospovidone E00626 Not Available Disintegrant
Ferric hydroxide oxide yellow E00539 23320441 Colorant
Haematite red E00236 14833 Colorant
Hydrophobic colloidal silica E00285 24261 Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Hypromellose E00634 Not Available Coating agent
Magnesium stearate E00208 11177 lubricant
Mannitol E00103 6251 Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Polyethylene glycol 4000 E00654 Not Available Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Povidone E00667 Not Available Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Sodium lauryl sulfate E00464 3423265 Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent